UNSPSC 51273826: Menthol/methyl nicotinate/methyl salicylate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE650. This VA Drug Class (DE650) classifies this compound as belonging to the group ANALGESICS, TOPICAL.

UNSPSC 51273826 Menthol/methyl nicotinate/methyl salicylate is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—requests naloxone and safe drug deactivation systems, products entirely outside the code's topical domain of pharmaceutical-grade chemical compounds used in topical pain and cooling preparations. The opportunity calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year initial term with one-year renewal option and a three-month probationary termination period.

The naloxone procurement represents an opioid-overdose emergency-response initiative rather than a chemical-commodity purchase aligned with the code's original taxonomy. No other recent state and local solicitations under this UNSPSC code appear in the data. Seminole County is the sole issuing body visible in the recent record, and the geographic spread therefore extends only to central Florida. The due date for the IFB was July 26, 2023, which is substantially in the past relative to today's date. This code warrants close attention only if pursuing naloxone or drug-deactivation-system supply contracts; the apparent tagging error suggests that state procurement offices may be using this code inconsistently or that the code's scope has drifted from its original intent in practice.